HOME › DRUGS › REGORAFENIB
ACTIVE SUBSTANCE / INN

REGORAFENIB

Brand name(s): Stivarga, STIVARGA, REGORAFENIB
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Colorectal Neoplasms
NDA203085
ACTIVE SUBSTANCE
Regorafenib
REGULATORS
FDA · EMA
SPONSORS / MAH
ACTAVIS LABS FL, Bayer Pharma AG, BAYER HLTHCARE
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
STIVARGANDA203085BAYER HLTHCAREPrescription
REGORAFENIBANDA209728ACTAVIS LABS FLDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
StivargaBayer Pharma AGAuthorised26/08/2013Colorectal Neoplasms

FULL INTELLIGENCE ON REGORAFENIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →